Institutional Biosafety Committee (IBC)
An institutional committee created under the NIH Guidelines for Research Involving Recombinant DNA Molecules to review research involving recombinant DNA. The role of IBCs has evolved over time, and many committees also review other forms of research that entail biohazardous risks as part of their institutionally assigned responsibilities. (Source: NIH, Office of Biotechnology)